Welcure Drugs & Pharmaceuticals Ltd share price
You have to be logged in to add this to Watchlist.- ₹0.26(-3.70%)June 10, 2026 15:55:58 PM IST
- NSE
- BSE
- Vol : 4.97 M (NSE + BSE)Last 20 day avg : 6.59 M
Welcure Drugs & Pharmaceuticals Ltd is trading -3.70% lower at Rs 0.26 as compared to its last closing price. Welcure Drugs & Pharmaceuticals Ltd has been trading in the price range of 0.28 & 0.26. Welcure Drugs & Pharmaceuticals Ltd has given -35.71% in this year & 0.00% in the last 5 days. The company posted a net profit of -49.86 Crores in its last quarter.Listed peers of Welcure Drugs & Pharmaceuticals Ltd include Dr Reddy's Laboratories (0.40%), Cipla (-0.31%), Sun Pharmaceutical Industries (0.48%).The Mutual Fund holding in Welcure Drugs & Pharmaceuticals Ltd was at -% in . The MF holding has - from the last quarter. The FII holding in Welcure Drugs & Pharmaceuticals Ltd was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jun 11, 2026, 01:45 AM UTC
- BetaMedium volatility0.93Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.00The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Dr Reddy's Laboratories | Neutral | 1,273.85 | 0.40 | 1,06,317.81 | 18.63 | 3.14 | 0.63 | 2.34 |
| Cipla | Neutral | 1,372.55 | -0.31 | 1,10,874.66 | 22.95 | 3.87 | 0.87 | 0.81 |
| Sun Pharmaceutical Industries | Neutral | 1,787.95 | 0.48 | 4,28,713.97 | 36.24 | 5.77 | 0.92 | 0.50 |
| Torrent Pharmaceuticals | Bullish | 4,453.05 | -0.44 | 1,50,929.78 | 67.32 | 17.1 | 0.83 | 17.62 |
| Divi's Laboratories | Bullish | 6,649.50 | -1.58 | 1,76,481.54 | 78.61 | 11.52 | 0.46 | 0.01 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-29 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-12-05 | Right Issue of Equity Shares |
| 2025-11-27 | To consider raisinf of funds |
| 2025-11-13 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE331C01025
- BSE Code524661
- NSE Code
Welcure Drugs & Pharmaceuticals Ltd is trading at 0.26 as on Wed Jun 10 2026 10:25:58. This is -3.70% lower as compared to its previous closing price of 0.27.
The market capitalization of Welcure Drugs & Pharmaceuticals Ltd is 32.13 Cr as on Wed Jun 10 2026 10:25:58.
The 52 wk high for Welcure Drugs & Pharmaceuticals Ltd is 1.44 whereas the 52 wk low is 0.23
Welcure Drugs & Pharmaceuticals Ltd can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 28.63
- Dividend Yield: 0.00%
- D/E ratio: 0.00
Welcure Drugs & Pharmaceuticals Ltd reported a net profit of -5.49 Cr in 2026.
EQUITY QUICK LINKS
Welcure Drugs & Pharmaceuticals Ltd QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.